Active	Status	Sponsor type	Region	Phase	Filter
2 Active 3 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Pellacani, Giovanni
DRESDA, NCT04483856: Efficacy and Tolerability Evaluation of a Topical MD Based on SHBF in Management of Radiodermatitis.	Completed	N/A	70	Europe	DermoRelizema cream, Dexeryl	Relife Italia S.r.l.	Radiodermatitis, Dermatitis, Radiation-Induced	02/23	02/23
NCT05971355: Comparison of LimpiAD Cream 2.5% Plus Versus Vehicle and an Emollient in Patients With Atopic Dermatitis	Recruiting	N/A	200	Europe	LimpiAD cream 2,5% plus, Vehicle, Emollient	Aileens Pharma SRL	Atopic Dermatitis	12/24	12/24